126 related articles for article (PubMed ID: 1702695)
1. Advances in the use of tumor markers.
Schwartz MK
Compr Ther; 1990 Nov; 16(11):51-7. PubMed ID: 1702695
[No Abstract] [Full Text] [Related]
2. [Radioimmunoassays in oncology].
Dressler J
Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in urology.
Grossman HB
Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
[No Abstract] [Full Text] [Related]
4. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
Bellet D; Bidart JM
Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
[No Abstract] [Full Text] [Related]
5. [Tumor markers].
Cappelaere P
Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
[No Abstract] [Full Text] [Related]
6. [Sense and nonsense of tumor markers in practice].
Joss R; Cerny T
Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers in prostatic cancer.
Schacht MJ; Garnett JE; Grayhack JT
Urol Clin North Am; 1984 May; 11(2):253-67. PubMed ID: 6203205
[TBL] [Abstract][Full Text] [Related]
8. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
Cooper EH; Siddall JK; Newling DW; Robinson MR
Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
[No Abstract] [Full Text] [Related]
9. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
10. Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S; Miyake H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
[No Abstract] [Full Text] [Related]
11. [Laboratory findings in tumor patients. II].
Wolff J; Anger G
Z Arztl Fortbild (Jena); 1980 May; 74(10):469-73. PubMed ID: 6158804
[No Abstract] [Full Text] [Related]
12. [Clinical significance of present tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
[TBL] [Abstract][Full Text] [Related]
13. Strategies for heterogeneous enzyme immunoassays for tumor markers.
King WJ; Tomita JT; Dowell BL; Delfert DM
Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
[No Abstract] [Full Text] [Related]
14. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
[No Abstract] [Full Text] [Related]
15. [Tissue polypeptide antigen. A new serum marker in pulmonary carcinoma].
Purello D'Ambrosio F; Angiò LG; Ruggeri P
Minerva Med; 1989 Jul; 80(7):687-8. PubMed ID: 2476686
[No Abstract] [Full Text] [Related]
16. [Clinical evaluation of tumor markers in patients with colorectal cancer].
Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
[TBL] [Abstract][Full Text] [Related]
17. Serum tumor markers.
Klee GG; Go VL
Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
[No Abstract] [Full Text] [Related]
18. [Tumor markers in liver metastasis of tumors of the colon and rectum].
Caruso U; Cravotto E; Lombardo PA; Caruso C; Silvaroli M; Tavolaro M; Casciani CU
G Chir; 1988 Jun; 9(6):431-3. PubMed ID: 2484646
[No Abstract] [Full Text] [Related]
19. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
Gebauer G; Müller-Ruchholtz W
Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
[TBL] [Abstract][Full Text] [Related]
20. Use of multiple markers to enhance clinical utility.
Mercer DW
Immunol Ser; 1990; 53():39-54. PubMed ID: 2100569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
